Skip to content
healthcare.dev

IRESSA

NDC 0310-0482, Gefitinib, tablet, coated, from AstraZeneca Pharmaceuticals LP.

Product NDC
0310-0482
Status
Listed
Labeler
AstraZeneca Pharmaceuticals LP
Dosage form
TABLET, COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA206995
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0310-0482 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GEFITINIB250 mg/1

Pharmacologic classes

Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]

Package NDCNDC-11Package
0310-0482-300031004823030 TABLET, COATED in 1 BOTTLE (0310-0482-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/827d60e8-7e07-41b7-c28b-49ef1c4a5a41

Use it

Look up 0310-0482 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0310-0482 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0310-0482. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.